{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T18:38:16Z","timestamp":1776710296831,"version":"3.51.2"},"reference-count":79,"publisher":"Informa UK Limited","issue":"2","funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2021.05149.BD, CEECIND\/02423\/2018, EXPL\/BIA-BQM\/0492\/2021, LA\/P\/0056\/2020, PTDC\/ASP-PES\/28397\/2017, PTDC\/MED-QUI\/29164\/2017, UIDB\/00081\/2020"],"award-info":[{"award-number":["2021.05149.BD, CEECIND\/02423\/2018, EXPL\/BIA-BQM\/0492\/2021, LA\/P\/0056\/2020, PTDC\/ASP-PES\/28397\/2017, PTDC\/MED-QUI\/29164\/2017, UIDB\/00081\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2020-116076RJ-I00\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["PID2020-116076RJ-I00\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Med. Chem."],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.4155\/fmc-2022-0243","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T09:28:54Z","timestamp":1676971734000},"page":"211-224","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":20,"title":["Propargylamine: an Important Moiety in Drug Discovery"],"prefix":"10.1080","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7415-5588","authenticated-orcid":false,"given":"Aitor","family":"Carneiro","sequence":"first","affiliation":[{"name":"CIQUP-IMS\/Department of Chemistry & Biochemistry Faculty of Sciences University of Porto\rRua do Campo Alegre 687\rPorto\r4169-007\rPortugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6218-2899","authenticated-orcid":false,"given":"Eugenio","family":"Uriarte","sequence":"additional","affiliation":[{"name":"Departamento de Qu\u00edmica Org\u00e1nica Facultade de Farmacia Universidade de Santiago de Compostela\rSantiago de Compostela\r15782\rSpain"},{"name":"Instituto de Ciencias Qu\u00edmicas Aplicadas Universidad Aut\u00f3noma de Chile\rSantiago\r7500912\rChile"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1050-2402","authenticated-orcid":false,"given":"Fernanda","family":"Borges","sequence":"additional","affiliation":[{"name":"CIQUP-IMS\/Department of Chemistry & Biochemistry Faculty of Sciences University of Porto\rRua do Campo Alegre 687\rPorto\r4169-007\rPortugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3470-8299","authenticated-orcid":false,"given":"Maria Jo\u00e3o","family":"Matos","sequence":"additional","affiliation":[{"name":"CIQUP-IMS\/Department of Chemistry & Biochemistry Faculty of Sciences University of Porto\rRua do Campo Alegre 687\rPorto\r4169-007\rPortugal"},{"name":"Departamento de Qu\u00edmica Org\u00e1nica Facultade de Farmacia Universidade de Santiago de Compostela\rSantiago de Compostela\r15782\rSpain"}]}],"member":"301","published-online":{"date-parts":[[2023,2,21]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/cber.189102402140"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrev.7b00343"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1039\/c3an36758d"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201700550"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc.15.12"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1039\/D0CC00255K"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm501722s"},{"issue":"2","key":"e_1_3_4_10_1","first-page":"147","article-title":"Metabolism and pharmacokinetics, in the rat, of (R)-N-(2-heptyl)methyl-propargylamine (R-2HMP), a new potent monoamine oxidase inhibitor and antiapoptotic agent","volume":"28","author":"Durden DA","year":"2000","unstructured":"Durden DA , DyckLE, DavisBA, LiuYD, BoultonAA. Metabolism and pharmacokinetics, in the rat, of (R)-N-(2-heptyl)methyl-propargylamine (R-2HMP), a new potent monoamine oxidase inhibitor and antiapoptotic agent. Drug Metab. Dispos.28(2), 147\u2013154 (2000).","journal-title":"Drug Metab. Dispos."},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/00498254.2017.1342288"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b01617"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-018-1952-7"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2018.1427735"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2018.01.003"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1021\/ja076090q"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.3390\/chemistry3030069"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1963.tb13332.x"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00324a009"},{"issue":"1","key":"e_1_3_4_20_1","first-page":"154","article-title":"Phenylisopropylmethylpropinylamine (E-250), a new spectrum psychic energizer","volume":"155","author":"Knoll J","year":"1965","unstructured":"Knoll J , EcseriZ, KelemenK, NievelJ, KnollB. Phenylisopropylmethylpropinylamine (E-250), a new spectrum psychic energizer. Arch. Int. Pharmacodyn. Ther.155(1), 154\u2013164 (1965).","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(68)90066-X"},{"key":"e_1_3_4_22_1","first-page":"393","article-title":"Some puzzling pharmacological effects of monoamine oxidase inhibitors","volume":"5","author":"Knoll J","year":"1972","unstructured":"Knoll J , MagyarK. Some puzzling pharmacological effects of monoamine oxidase inhibitors. Adv. Biochem. Psychopharmacol.5, 393\u2013408 (1972).","journal-title":"Adv. Biochem. Psychopharmacol."},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-0348-6348-3_4"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1353-8020(99)00043-7"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.9b00147"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-018-1861-9"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25245908"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2018.00169"},{"issue":"2","key":"e_1_3_4_29_1","first-page":"S5","article-title":"Structure of the human mitochondrial monoamine oxidase B: new chemical implications for neuroprotectant drug design","volume":"67","author":"Binda C","year":"2006","unstructured":"Binda C , HubalekF, LiM, CastagnoliN, EdmondsonDE, MatteviA. Structure of the human mitochondrial monoamine oxidase B: new chemical implications for neuroprotectant drug design. Neurology67(2 Suppl. 7), S5\u2013S7 (2006).","journal-title":"Neurology"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm0506266"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b01886"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202000018"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.6b00377"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.105301"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.9b00081"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm7009364"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202000454"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc.14.9"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules20023290"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm020120c"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.2174\/138945012799499794"},{"key":"e_1_3_4_42_1","unstructured":"Avraham Pharmaceuticals Ltd Avraham Pharmaceuticals Ltd. Safety and efficacy study of ladostigil in mild to moderate probable Alzheimer's disease.. ClinicalTrials.govhttps:\/\/clinicaltrials.gov\/ct2\/show\/NCT01354691 (Accessed 22February2022)."},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm200853t"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2014.04.078"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2017.08.025"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.8b00357"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2016.06.013"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2016.11.032"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-015-0067-y"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2016.00294"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/cns.12590"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.6b00122"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2018.11.051"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.03-0078fje"},{"key":"e_1_3_4_55_1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/978-3-211-45295-0_68","volume-title":"Parkinson's Disease and Related Disorders.","author":"Gal S","year":"2006","unstructured":"Gal S , FridkinM, AmitT, ZhengH, M30, a novel multifunctional neuroprotective drug with potent iron chelating and brain selective monoamine oxidase-Ab inhibitory activity for Parkinson's disease. In: Parkinson's Disease and Related Disorders.YoudimMBH, RiedererP, ReichmannH, GerlachM (Eds). Springer, Vienna, Austria447\u2013456 (2006)."},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.5607\/en.2013.22.1.1"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abf9180"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2021.128135"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-012-0899-3"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1039\/D0OB00280A"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.201200428"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201700550"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm400792m"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/chem.202000335"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1039\/C5CC00530B"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.03.061"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm2004688"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm9502652"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm500422b"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b00084"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1039\/b904091a"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1039\/C5CC04571A"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1039\/C5DT00576K"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1039\/b917832e"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2013.05.033"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1039\/c2ob25752a"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2019.12.007"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1039\/C5CC04571A"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio859"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2011.07.043"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejic.201200628"}],"container-title":["Future Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.4155\/fmc-2022-0243","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T19:51:44Z","timestamp":1716493904000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4155\/fmc-2022-0243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.4155\/fmc-2022-0243"],"URL":"https:\/\/doi.org\/10.4155\/fmc-2022-0243","relation":{},"ISSN":["1756-8919","1756-8927"],"issn-type":[{"value":"1756-8919","type":"print"},{"value":"1756-8927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmc20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmc20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-09-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}